Bryan C. Fuchs
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Biochemistry top 0.5%
- Amino Acid Enzymes and Metabolism
Papers in
- Epidemiology 31
- Liver Disease Diagnosis and Treatment 24
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Liver physiology and pathology 12
- Liver Disease and Transplantation 7
- Co-authors
- Barrie P. Bode (6 shared papers)Kenneth K. Tanabe (66 shared papers)Peter Caravan (30 shared papers)Michael Lanuti (25 shared papers)Tsutomu Fujii (12 shared papers)Raymond T. Chung (13 shared papers)Jonathan M. Goodwin (5 shared papers)Gregory Y. Lauwers (12 shared papers)
- Journals
- Journal of Hepatology (9 papers)Scientific Reports (6 papers)Cancer Research (6 papers)Hepatology (3 papers)Investigative Radiology (3 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Bryan C. Fuchs
103 papers receiving 4.8k citations
Bryan C. Fuchs's Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 1.0k
- Biochemistry 559
- Cancer Research 789
- Epidemiology 1.1k
- Oncology 885
Countries citing papers authored by Bryan C. Fuchs
This map shows the geographic impact of Bryan C. Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan C. Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan C. Fuchs more than expected).
Fields of papers citing papers by Bryan C. Fuchs
This network shows the impact of papers produced by Bryan C. Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan C. Fuchs. The network helps show where Bryan C. Fuchs may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan C. Fuchs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? Hit paper breakdown → | 2005 | 570 |
| 2 | 2008 | 263 | |
| 3 | 2014 | 167 | |
| 4 | 2008 | 165 | |
| 5 | 2020 | 160 | |
| 6 | 2010 | 152 | |
| 7 | 2017 | 134 | |
| 8 | 2013 | 119 | |
| 9 | 2019 | 114 | |
| 10 | 2007 | 112 | |
| 11 | 2011 | 108 | |
| 12 | 2013 | 107 | |
| 13 | 2019 | 97 | |
| 14 | 2002 | 91 | |
| 15 | 2012 | 90 | |
| 16 | 2006 | 89 | |
| 17 | 2018 | 88 | |
| 18 | 2013 | 84 | |
| 19 | 2018 | 79 | |
| 20 | 2016 | 75 |
About Bryan C. Fuchs
Bryan C. Fuchs is a scholar working on Epidemiology, Hepatology, Molecular Biology, Oncology and Cancer Research, having authored 105 papers that have together received 4.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver physiology and pathology (12 papers), Cancer Cells and Metastasis (9 papers), Liver Disease and Transplantation (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Hepatology (1.0k citations), Biochemistry (559 citations), Cancer Research (789 citations), Epidemiology (1.1k citations) and Oncology (885 citations). Bryan C. Fuchs has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Barrie P. Bode, Kenneth K. Tanabe, Peter Caravan, Michael Lanuti, Tsutomu Fujii, Raymond T. Chung, Jonathan M. Goodwin, Gregory Y. Lauwers, Yujin Hoshida and Suguru Yamada. Their work appears in journals such as Journal of Hepatology, Scientific Reports, Cancer Research, Hepatology and Investigative Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.